FindTrial
Sign In

A study for effect of diabetes on rebleeding after endoscopic treatment in patients with liver cirrhosis

A study for effect of diabetes on rebleeding after endoscopic treatment in patients with liver cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017772
Enrollment
Unknown
Registered
2018-08-13
Start date
2018-08-20
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal varices

Interventions

Group 1:endoscopic esophageal variceal ligation
Group 2:endoscopic injection sclerotherapy

Sponsors

the First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Aged 18-75 years old; Patients diagnosed with cirrhosis complicated with esophageal varices; Patients with a history of variceal bleeding and treated by endoscopic injection sclerotherapy or endoscopic esophageal variceal ligation .

Exclusion criteria

Exclusion criteria: Other parts of bleeding; Gastrointestinal bleeding caused by other causes; Patients with blood system diseases; patients with severe organ comorbidities and malignant tumors.

Design outcomes

Primary

MeasureTime frame
Postoperative bleeding rate;—

Countries

China

Contacts

Public ContactDerun Kong

the First Affiliated Hospital of Anhui Medical University

kongderun168@163.com+86 13955155476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026